Current treatment paradigm and survival outcomes among patients with newly diagnosed multiple myeloma in China: a retrospective multicenter study

Current treatment paradigm and survival outcomes among patients with newly diagnosed multiple myeloma in China: a retrospective multicenter study

Objective: Evidence on the prognostic value of autologous stem cell transplantation (ASCT) and minimal residual disease (MRD) dynamics of patients with newly diagnosed multiple myeloma (NDMM) in China is limited. Our objective in the current study was to understand the current care paradigm and outc...

Full description

Bibliographic Details
Main Authors: Huishou Fan, Weida Wang, Ya Zhang, Jianxiang Wang, Tao Cheng, Lugui Qiu, Xin Wang, Zhongjun Xia, Gang An
Format: Article
Language:English
Published: China Anti-Cancer Association 2023-01-01
Series:Cancer Biology & Medicine
Subjects:
multiple myeloma
autologous stem cell transplantation
minimal residual disease
survival outcomes
multicenter study
Online Access:https://www.cancerbiomed.org/content/20/1/77

Internet

https://www.cancerbiomed.org/content/20/1/77

Similar Items